Myalgia with the presence of pathologic EMG correlates with perimysial inflammatory infiltrates

肌痛伴病理性肌电图与肌束膜炎性浸润相关

阅读:1

Abstract

OBJECTIVE: We aimed to define normal numbers of inflammatory cells in muscle biopsies and to identify the predictive value of isolated muscle pain and increased creatine kinase regarding the diagnosis of myositis. METHODS: We analyzed muscle biopsies of 71 patients using immunostains for CD3(+), CD4(+), CD8(+), CD68(+), major histocompatibility complex class I, perforin, and myeloid-related protein (MRP) 8. Patients were categorized as follows-group 1: myalgia without further clinical or laboratory abnormalities (n = 24); group 2: asymptomatic elevation of creatine kinase (hyperCKemia, n = 26); group 3: myalgia and pathologic EMG findings (n = 9); and group 4: otherwise healthy controls who had malignant hyperthermia susceptibility testing (n = 12). RESULTS: In the normal muscle biopsy specimens from group 4, mean endomysial macrophage (CD68(+)) density was 21.7 ± 5.6/mm(2), and perimysial density was 13.0 ± 5.6/mm(2). Numbers of T-lymphocytes (CD3(+)) were 5 ± 3.5 endomysially and 2.2 ± 3.9/mm(2) perimysially. This was not different from groups 1 and 2. Only group 3 patients had increased mean numbers of perimysial macrophages (24.1 ± 6.3/mm(2); p = 0.0005), CD3(+) (7.6 ± 4.9/mm(2); p = 0.0056), and CD8(+) T-lymphocytes (5.4 ± 3.1/mm(2); p = 0.0008) and displayed the activation marker MRP8 in all cases. Although inflammatory cells were increased in the perimysium in group 3, histology did not fulfill the criteria for dermatomyositis, polymyositis, or inclusion body myositis. CONCLUSIONS: Normal muscle contains a considerable number of macrophages and T-lymphocytes. Muscle biopsy is likely to detect inflammatory changes in patients with myalgia or hyperCKemia only if pathologic EMG findings are present.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。